Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Regeneron Pharmaceuticals - 33 Year Stock Price History | REGN

Historical daily share price chart and data for Regeneron Pharmaceuticals since 1991 adjusted for splits and dividends. The latest closing stock price for Regeneron Pharmaceuticals as of April 26, 2024 is 883.20.
  • The all-time high Regeneron Pharmaceuticals stock closing price was 993.35 on February 27, 2024.
  • The Regeneron Pharmaceuticals 52-week high stock price is 998.33, which is 13% above the current share price.
  • The Regeneron Pharmaceuticals 52-week low stock price is 684.80, which is 22.5% below the current share price.
  • The average Regeneron Pharmaceuticals stock price for the last 52 weeks is 840.60.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Regeneron Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 942.8983 905.0000 993.3500 883.2000 883.2000 0.56%
2023 783.8250 720.4700 881.7000 680.4900 878.2900 21.73%
2022 662.5164 627.1000 766.3900 548.3500 721.4900 14.25%
2021 558.3248 482.8600 680.9600 446.7300 631.5200 30.72%
2020 532.3580 373.3500 658.2100 336.1800 483.1100 28.66%
2019 343.5064 372.4400 439.5700 273.4600 375.4800 0.53%
2018 351.6680 382.6000 408.5100 284.6000 373.5000 -0.65%
2017 422.4830 379.7000 526.5300 340.7500 375.9600 2.42%
2016 394.5000 516.5500 519.4800 331.0500 367.0900 -32.38%
2015 498.7331 410.1600 592.4000 396.8900 542.8700 32.33%
2014 333.6675 274.5900 434.9500 267.6200 410.2500 49.05%
2013 239.8612 181.2000 316.6320 158.4200 275.2400 60.89%
2012 130.8339 56.4300 187.7400 56.4300 171.0700 208.62%
2011 51.1067 33.8200 72.1900 32.6100 55.4300 68.84%
2010 26.2129 24.6300 33.6900 20.7900 32.8300 35.77%
2009 17.7172 18.7000 24.7400 12.0500 24.1800 31.70%
2008 18.9787 23.5600 24.7500 13.3500 18.3600 -23.98%
2007 20.5494 19.8100 28.6000 13.6600 24.1500 20.33%
2006 16.1155 15.9000 24.2800 11.1200 20.0700 26.23%
2005 8.2982 9.0400 16.8300 4.6300 15.9000 72.64%
2004 10.8352 15.0500 16.7200 6.8500 9.2100 -37.39%
2003 14.7557 19.0900 22.3050 5.8800 14.7100 -20.53%
2002 18.8848 27.9200 29.3100 11.3600 18.5100 -34.27%
2001 28.3779 35.5600 39.0000 20.6000 28.1600 -20.16%
2000 27.3401 12.3100 56.5000 11.6300 35.2700 176.63%
1999 7.8169 7.9380 12.7500 5.5630 12.7500 72.88%
1998 8.1477 8.8750 10.9400 5.8750 7.3750 -13.87%
1997 9.8900 17.1300 19.3800 6.5000 8.5630 -46.88%
1996 16.2382 13.2500 24.6250 11.8750 16.1200 26.43%
1995 9.5972 3.3130 16.9400 3.3130 12.7500 325.00%
1994 7.0362 15.2500 17.2500 3.0000 3.0000 -80.65%
1993 15.5031 12.0000 21.5000 11.0000 15.5000 29.17%
1992 13.0192 18.7500 22.5000 8.0000 12.0000 -33.81%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $97.763B $13.117B
Regeneron is a biotechnology company focused on the discovery, development and commercialization of treatments targeting serious medical conditions. The company's portfolio boasts nine marketed drugs - Eylea, Dupixent, Praluent, Kevzara, Libtayo, Evkeeza, Inmazeb Arcalyst and Zaltrap. The company also developed an antibody cocktail for COVID-19, REGEN-COV. REGEN-COV is a cocktail of two monoclonal antibodies and was designed specifically to block the infectivity of SARS-CoV-2, the virus that causes COVID-19. Regeneron has a collaboration agreement with Roche for the same. While Regeneron has co-developed Eylea with Bayer's HealthCare unit, Praluent was co-developed with Sanofi. Regeneron collaborated with Bayer for the joint development and commercialization of co-formulated combinations of Eylea, rinucumab and nesvacumab for the treatment of ocular diseases or disorders outside the United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $144.489B 14.44
Vertex Pharmaceuticals (VRTX) United States $102.789B 29.59
Bristol Myers Squibb (BMY) United States $90.596B 6.08
CSL (CSLLY) Australia $87.140B 0.00
GSK (GSK) United Kingdom $84.784B 10.63
Gilead Sciences (GILD) United States $81.266B 16.20
Moderna (MRNA) United States $40.654B 0.00
Biogen (BIIB) United States $29.478B 13.50
Argenex SE (ARGX) Netherlands $21.906B 0.00
BioNTech SE (BNTX) Germany $20.613B 21.05
Illumina (ILMN) United States $19.278B 139.14
Genmab (GMAB) Denmark $18.157B 23.27
Alnylam Pharmaceuticals (ALNY) United States $18.100B 0.00
BioMarin Pharmaceutical (BMRN) United States $15.508B 60.87
BeiGene (BGNE) Cayman Islands $14.208B 0.00
Sarepta Therapeutics (SRPT) United States $12.039B 0.00
Incyte (INCY) United States $11.491B 19.10
Exact Sciences (EXAS) United States $10.672B 0.00
Bio-Techne Corp (TECH) United States $9.850B 36.64
QIAGEN (QGEN) Netherlands $9.375B 19.41
Repligen (RGEN) United States $9.250B 95.76
Roivant Sciences (ROIV) United Kingdom $8.768B 0.00
Legend Biotech (LEGN) United States $8.080B 0.00
Bio-Rad Laboratories (BIO.B) United States $7.983B 23.78
Ascendis Pharma (ASND) Denmark $7.973B 0.00
Viking Therapeutics (VKTX) United States $7.590B 0.00
Intra-Cellular Therapies (ITCI) United States $6.983B 0.00
Exelixis (EXEL) United States $6.937B 36.77
Cytokinetics (CYTK) United States $6.777B 0.00
Vaxcyte (PCVX) United States $6.532B 0.00
Apellis Pharmaceuticals (APLS) United States $5.779B 0.00
Blueprint Medicines (BPMC) United States $5.553B 0.00
Halozyme Therapeutics (HALO) United States $4.887B 15.08
CRISPR Therapeutics AG (CRSP) Switzerland $4.561B 0.00
Krystal Biotech (KRYS) United States $4.439B 0.00
Zealand Pharma (ZLDPF) Denmark $4.439B 0.00
Nuvalent (NUVL) United States $4.233B 0.00
Alkermes (ALKS) Ireland $4.135B 21.82
Immunovant (IMVT) United States $4.032B 0.00
Insmed (INSM) United States $3.702B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.609B 0.00
ImmunityBio (IBRX) United States $3.459B 0.00
Biohaven (BHVN) United States $3.401B 0.00
Axsome Therapeutics (AXSM) United States $3.388B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.309B 0.00
SpringWorks Therapeutics (SWTX) United States $3.261B 0.00
Fortrea Holdings (FTRE) United States $3.249B 0.00
Iovance Biotherapeutics (IOVA) United States $3.223B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.025B 0.00
Amicus Therapeutics (FOLD) United States $3.012B 0.00
Immunocore Holdings (IMCR) United Kingdom $2.890B 0.00
IDEAYA Biosciences (IDYA) United States $2.887B 0.00
Arcellx (ACLX) United States $2.738B 0.00
MorphoSys AG (MOR) Germany $2.731B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.699B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.687B 0.00
Merus (MRUS) Netherlands $2.637B 0.00
Certara (CERT) United States $2.611B 56.21
Janux Therapeutics (JANX) United States $2.433B 0.00
CG Oncology (CGON) United States $2.412B 0.00
Rhythm Pharmaceuticals (RYTM) United States $2.294B 0.00
Vericel (VCEL) United States $2.199B 0.00
Arvinas (ARVN) United States $2.159B 0.00
Denali Therapeutics (DNLI) United States $2.132B 0.00
Vera Therapeutics (VERA) United States $2.107B 0.00
Guardant Health (GH) United States $2.089B 0.00
Kymera Therapeutics (KYMR) United States $2.046B 0.00
Celldex Therapeutics (CLDX) United States $2.027B 0.00
Rocket Pharmaceuticals (RCKT) United States $2.000B 0.00
Apogee Therapeutics (APGE) United States $1.968B 0.00
Keros Therapeutics (KROS) United States $1.955B 0.00
Geron (GERN) United States $1.947B 0.00
Intellia Therapeutics (NTLA) United States $1.931B 0.00
Avidity Biosciences (RNA) United States $1.900B 0.00
Galapagos (GLPG) Belgium $1.887B 0.00
Sana Biotechnology (SANA) United States $1.874B 0.00
Structure Therapeutics (GPCR) United States $1.816B 0.00
Twist Bioscience (TWST) United States $1.797B 0.00
Beam Therapeutics (BEAM) United States $1.778B 0.00
NeoGenomics (NEO) United States $1.768B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.748B 0.00
Ginkgo Bioworks Holdings (DNA) United States $1.674B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.643B 13.65
Myriad Genetics (MYGN) United States $1.627B 0.00
Bavarian Nordic (BVNRY) Denmark $1.621B 5.32
Inhibrx (INBX) United States $1.616B 0.00
Zai Lab (ZLAB) China $1.562B 0.00
Edgewise Therapeutics (EWTX) United States $1.484B 0.00
ADMA Biologics Inc (ADMA) United States $1.470B 0.00
Dynavax Technologies (DVAX) United States $1.462B 0.00
Kura Oncology (KURA) United States $1.447B 0.00
Neumora Therapeutics (NMRA) United States $1.440B 0.00
Protagonist Therapeutics (PTGX) United States $1.437B 0.00
Morphic Holding (MORF) United States $1.400B 0.00
Gyre Therapeutics (GYRE) United States $1.395B 0.00
ANI Pharmaceuticals (ANIP) United States $1.369B 16.83
Arcus Biosciences (RCUS) United States $1.340B 0.00
Akero Therapeutics (AKRO) United States $1.309B 0.00
Ligand Pharmaceuticals (LGND) United States $1.246B 15.43
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.244B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $1.237B 0.00
Spyre Therapeutics (SYRE) United States $1.174B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.154B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.154B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.146B 0.00
MannKind (MNKD) United States $1.131B 0.00
Belite Bio (BLTE) United States $1.108B 0.00
Prothena (PRTA) Ireland $1.104B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.102B 0.00
Scholar Rock Holding (SRRK) United States $1.087B 0.00
Autolus Therapeutics (AUTL) United Kingdom $1.085B 0.00
AbCellera Biologics (ABCL) Canada $1.063B 0.00
Vir Biotechnology (VIR) United States $1.026B 0.00
Abivax SA (ABVX) France $0.991B 0.00
Liquidia Technologies (LQDA) United States $0.940B 0.00
MiMedx (MDXG) United States $0.922B 208.17
Immunome (IMNM) United States $0.851B 0.00
ALX Oncology Holdings (ALXO) United States $0.844B 0.00
Arcutis Biotherapeutics (ARQT) United States $0.832B 0.00
Cullinan Therapeutics (CGEM) United States $0.829B 0.00
Immatics (IMTX) Germany $0.828B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.805B 0.00
Viridian Therapeutics (VRDN) United States $0.797B 0.00
Tyra Biosciences (TYRA) United States $0.794B 0.00
REGENXBIO (RGNX) United States $0.788B 0.00
89BIO (ETNB) United States $0.786B 0.00
Tango Therapeutics (TNGX) United States $0.782B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.780B 0.00
PureTech Health (PRTC) United States $0.742B 0.00
Cytek Biosciences (CTKB) United States $0.737B 0.00
CARGO Therapeutics (CRGX) United States $0.720B 0.00
Pliant Therapeutics (PLRX) United States $0.717B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.704B 0.00
Mesoblast (MESO) Australia $0.702B 0.00
Pharming Group (PHAR) Netherlands $0.701B 0.00
Praxis Precision Medicines (PRAX) United States $0.700B 0.00
Longboard Pharmaceuticals (LBPH) United States $0.693B 0.00
Kyverna Therapeutics (KYTX) United States $0.687B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.677B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.650B 0.00
EnGene Holdings (ENGN) United States $0.642B 0.00
Disc Medicine (IRON) United States $0.640B 0.00
Dianthus Therapeutics (DNTH) United States $0.616B 0.00
Stoke Therapeutics (STOK) United States $0.609B 0.00
Nurix Therapeutics (NRIX) United States $0.608B 0.00
Aerovate Therapeutics (AVTE) United States $0.601B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.599B 0.00
HilleVax (HLVX) United States $0.598B 0.00
Pharming Group (PHGUF) Netherlands $0.591B 0.00
WAVE Life Sciences (WVE) Singapore $0.580B 0.00
Cogent Biosciences (COGT) United States $0.575B 0.00
Northwest Biotherapeutics (NWBO) United States $0.574B 0.00
Zymeworks (ZYME) United States $0.572B 0.00
Nuvation Bio (NUVB) United States $0.571B 0.00
Cabaletta Bio (CABA) United States $0.570B 0.00
Novavax (NVAX) United States $0.553B 0.00
Olema Pharmaceuticals (OLMA) United States $0.550B 0.00
Mineralys Therapeutics (MLYS) United States $0.548B 0.00
GH Research (GHRS) Ireland $0.546B 0.00
Castle Biosciences (CSTL) United States $0.536B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.533B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.527B 0.00
ArriVent BioPharma (AVBP) United States $0.520B 0.00
CureVac (CVAC) Germany $0.517B 0.00
Oric Pharmaceuticals (ORIC) United States $0.517B 0.00
Prime Medicine (PRME) United States $0.516B 0.00
AnaptysBio (ANAB) United States $0.516B 0.00
Absci (ABSI) United States $0.504B 0.00
Astria Therapeutics (ATXS) United States $0.504B 0.00
Adlai Nortye (ANL) Cayman Islands $0.497B 0.00
Arbutus Biopharma (ABUS) United States $0.488B 0.00
Allogene Therapeutics (ALLO) United States $0.487B 0.00
Oculis Holding AG (OCS) Switzerland $0.484B 0.00
Applied Therapeutics (APLT) United States $0.483B 0.00
Celcuity (CELC) United States $0.480B 0.00
Shattuck Labs (STTK) United States $0.465B 0.00
Avid Bioservices (CDMO) United States $0.465B 0.00
Humacyte (HUMA) United States $0.464B 0.00
Alector (ALEC) United States $0.461B 0.00
IGM Biosciences (IGMS) United States $0.450B 0.00
Fulcrum Therapeutics (FULC) United States $0.443B 0.00
Fate Therapeutics (FATE) United States $0.440B 0.00
Editas Medicine (EDIT) United States $0.429B 0.00
C4 Therapeutics (CCCC) United States $0.428B 0.00
Third Harmonic Bio (THRD) United States $0.426B 0.00
ACELYRIN, INC (SLRN) United States $0.419B 0.00
Entrada Therapeutics (TRDA) United States $0.415B 0.00
Annexon (ANNX) United States $0.413B 0.00
Travere Therapeutics (TVTX) United States $0.410B 0.00
Voyager Therapeutics (VYGR) United States $0.403B 2.40
MaxCyte (MXCT) United States $0.385B 0.00
Neurogene (NGNE) United States $0.384B 0.00
FibroBiologics (FBLG) United States $0.381B 0.00
ITeos Therapeutics (ITOS) United States $0.380B 0.00
Alto Neuroscience (ANRO) United States $0.380B 0.00
Anika Therapeutics (ANIK) United States $0.380B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.379B 0.00
Adaptive Biotechnologies (ADPT) United States $0.379B 0.00
PepGen (PEPG) United States $0.379B 0.00
Replimune (REPL) United States $0.378B 0.00
Biomea Fusion (BMEA) United States $0.376B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.368B 0.00
Amarin (AMRN) Ireland $0.353B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.351B 0.00
Aura Biosciences (AURA) United States $0.350B 0.00
TScan Therapeutics (TCRX) United States $0.349B 0.00
Precigen (PGEN) United States $0.348B 0.00
Mersana Therapeutics (MRSN) United States $0.346B 0.00
Revance Therapeutics (RVNC) United States $0.343B 0.00
Caribou Biosciences (CRBU) United States $0.340B 0.00
Nkarta (NKTX) United States $0.337B 0.00
Tenaya Therapeutics (TNYA) United States $0.331B 0.00
Rani Therapeutics Holdings (RANI) United States $0.329B 0.00
Urogen Pharma (URGN) United States $0.324B 0.00
Solid Biosciences (SLDB) United States $0.323B 0.00
Jasper Therapeutics (JSPR) United States $0.319B 0.00
Atea Pharmaceuticals (AVIR) United States $0.311B 0.00
Ocugen (OCGN) United States $0.304B 0.00
MeiraGTx Holdings (MGTX) United States $0.302B 0.00
Terns Pharmaceuticals (TERN) United States $0.300B 0.00
Kamada (KMDA) Israel $0.299B 22.61
Nautilus Biotechnology (NAUT) United States $0.295B 0.00
XOMA (XOMA) United States $0.295B 0.00
Contineum Therapeutics (CTNM) United States $0.292B 0.00
Ventyx Biosciences (VTYX) United States $0.286B 0.00
Erasca (ERAS) United States $0.285B 0.00
CorMedix Inc (CRMD) United States $0.284B 0.00
Anavex Life Sciences (AVXL) United States $0.278B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.273B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.271B 0.00
Rapt Therapeutics (RAPT) United States $0.271B 0.00
Werewolf Therapeutics (HOWL) United States $0.269B 0.00
Inozyme Pharma (INZY) United States $0.267B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.262B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.258B 89.60
ChromaDex (CDXC) United States $0.255B 0.00
XBiotech (XBIT) United States $0.250B 0.00
Invivyd (IVVD) United States $0.247B 0.00
Renovaro (RENB) United States $0.244B 0.00
Inovio Pharmaceuticals (INO) United States $0.237B 0.00
Puma Biotechnology (PBYI) United States $0.235B 10.61
Verastem (VSTM) United States $0.233B 0.00
Prima BioMed (IMMP) Australia $0.229B 0.00
AC Immune (ACIU) Switzerland $0.226B 0.00
23andMe Holding (ME) United States $0.222B 0.00
2seventy Bio (TSVT) United States $0.220B 0.00
Coherus BioSciences (CHRS) United States $0.219B 0.00
UniQure (QURE) Netherlands $0.217B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.214B 0.00
Sutro Biopharma (STRO) United States $0.214B 0.00
Design Therapeutics (DSGN) United States $0.212B 0.00
Opthea (OPT) Australia $0.212B 0.00
Ovid Therapeutics (OVID) United States $0.212B 0.00
Compass Therapeutics (CMPX) United States $0.204B 0.00
G1 Therapeutics (GTHX) United States $0.202B 0.00
Lifecore Biomedical (LFCR) United States $0.201B 0.00
Poseida Therapeutics (PSTX) United States $0.198B 0.00
INmune Bio (INMB) United States $0.197B 0.00
Adverum Biotechnologies (ADVM) United States $0.195B 0.00
Innate Pharma S.A (IPHA) France $0.194B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.192B 0.00
X4 Pharmaceuticals (XFOR) United States $0.190B 0.00
Candel Therapeutics (CADL) United States $0.189B 0.00
Akoya Biosciences (AKYA) United States $0.189B 0.00
Codexis (CDXS) United States $0.186B 0.00
Cardiff Oncology (CRDF) United States $0.178B 0.00
Elevation Oncology (ELEV) United States $0.177B 0.00
Trevi Therapeutics (TRVI) United States $0.175B 0.00
Agenus (AGEN) United States $0.174B 0.00
Alimera Sciences (ALIM) United States $0.173B 0.00
GENFIT S.A (GNFT) France $0.172B 0.00
Adocia (ADOCY) France $0.169B 0.00
Kodiak Sciences (KOD) United States $0.167B 0.00
Inventiva S.A (IVA) France $0.166B 0.00
Compugen (CGEN) Israel $0.165B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.159B 0.00
Greenwich LifeSciences (GLSI) United States $0.159B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.159B 0.00
Skye Bioscience (SKYE) United States $0.159B 0.00
ScPharmaceuticals (SCPH) United States $0.157B 0.00
Zura Bio (ZURA) United States $0.156B 0.00
CervoMed (CRVO) United States $0.154B 0.00
BioStem Technologies (BSEM) $0.153B 0.00
Gossamer Bio (GOSS) United States $0.152B 0.00
Annovis Bio (ANVS) United States $0.150B 0.00
Adicet Bio (ACET) United States $0.149B 0.00
I-Mab (IMAB) China $0.146B 0.00
Scilex Holding (SCLX) United States $0.143B 0.00
Molecular Partners AG (MOLN) Switzerland $0.141B 0.00
Cellectis S.A (CLLS) France $0.138B 0.00
Syros Pharmaceuticals (SYRS) United States $0.136B 0.00
DBV Technologies S.A (DBVT) France $0.133B 0.00
Omega Therapeutics (OMGA) United States $0.130B 0.00
VistaGen Therapeutics (VTGN) United States $0.127B 0.00
Sagimet Biosciences (SGMT) United States $0.125B 0.00
Coya Therapeutics (COYA) United States $0.123B 0.00
PDS Biotechnology (PDSB) United States $0.120B 0.00
Repare Therapeutics (RPTX) Canada $0.117B 0.00
Vor Biopharma (VOR) $0.116B 0.00
Nuvectis Pharma (NVCT) United States $0.116B 0.00
Immunic (IMUX) United States $0.114B 0.00
Seer (SEER) United States $0.113B 0.00
Cartesian Therapeutics (RNAC) United States $0.113B 0.00
Seres Therapeutics (MCRB) United States $0.112B 0.00
CytomX Therapeutics (CTMX) United States $0.108B 0.00
ATyr Pharma (LIFE) United States $0.108B 0.00
TELA Bio (TELA) United States $0.108B 0.00
BioAtla (BCAB) United States $0.108B 0.00
Oncobiologics (OTLK) United States $0.107B 0.00
Sangamo Therapeutics (SGMO) United States $0.104B 0.00
Rezolute (RZLT) United States $0.104B 0.00
Adagene (ADAG) China $0.104B 0.00
Emergent Biosolutions (EBS) United States $0.102B 0.00
BioHarvest Sciences (CNVCF) Canada $0.102B 0.00
Bluebird Bio (BLUE) United States $0.100B 0.00
Vigil Neuroscience (VIGL) United States $0.097B 0.00
BioXcel Therapeutics (BTAI) United States $0.097B 0.00
DiaMedica Therapeutics (DMAC) United States $0.096B 0.00
IO Biotech (IOBT) Denmark $0.096B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.095B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.095B 0.00
Clearside Biomedical (CLSD) United States $0.094B 0.00
Elicio Therapeutics (ELTX) United States $0.093B 0.00
Q32 Bio (QTTB) United States $0.092B 0.00
Allakos (ALLK) United States $0.089B 0.00
Genelux (GNLX) United States $0.089B 0.00
BeyondSpring (BYSI) United States $0.088B 0.00
Abeona Therapeutics (ABEO) United States $0.087B 0.00
Curis (CRIS) United States $0.086B 0.00
Galena Biopharma (SLS) United States $0.086B 0.00
Aileron Therapeutics (ALRN) United States $0.085B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.084B 0.00
Atara Biotherapeutics (ATRA) United States $0.084B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.082B 0.00
InflaRx (IFRX) Germany $0.082B 0.00
Oncolytics Biotech (ONCY) Canada $0.081B 0.00
Leap Therapeutics (LPTX) United States $0.081B 0.00
Eton Pharmaceuticals (ETON) United States $0.080B 0.00
HOOKIPA Pharma (HOOK) United States $0.080B 0.00
Eupraxia Pharmaceuticals (EPRX) $0.078B 0.00
VTv Therapeutics (VTVT) United States $0.078B 0.00
Spero Therapeutics (SPRO) United States $0.077B 2.86
Cognition Therapeutics (CGTX) United States $0.075B 0.00
Passage Bio (PASG) United States $0.075B 0.00
Gritstone Bio (GRTS) United States $0.075B 0.00
Connect Biopharma Holdings (CNTB) United States $0.075B 0.00
Affimed (AFMD) Germany $0.074B 0.00
YS Biopharma (YS) China $0.074B 0.00
Athira Pharma (ATHA) United States $0.074B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.073B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.072B 0.00
Elutia (ELUT) United States $0.070B 0.00
Landos Biopharma (LABP) United States $0.070B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.070B 0.00
Alpha Teknova (TKNO) United States $0.069B 0.00
Cue Biopharma (CUE) United States $0.069B 0.00
AN2 Therapeutics (ANTX) United States $0.068B 0.00
Instil Bio (TIL) United States $0.068B 0.00
Precision BioSciences (DTIL) United States $0.067B 0.00
Turnstone Biologics (TSBX) United States $0.067B 0.00
MediciNova (MNOV) United States $0.065B 0.00
Equillium (EQ) United States $0.064B 0.00
Ikena Oncology (IKNA) United States $0.063B 0.00
Rallybio (RLYB) United States $0.062B 0.00
Aligos Therapeutics (ALGS) United States $0.062B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.061B 0.00
Celularity (CELU) United States $0.059B 0.00
Cidara Therapeutics (CDTX) United States $0.059B 0.00
Kronos Bio (KRON) United States $0.059B 0.00
Lantern Pharma (LTRN) United States $0.059B 0.00
Entera Bio (ENTX) Israel $0.058B 0.00
Kezar Life Sciences (KZR) United States $0.058B 0.00
CalciMedica (CALC) United States $0.057B 0.00
LENZ Therapeutics (LENZ) United States $0.056B 0.00
Immix Biopharma (IMMX) United States $0.055B 0.00
HCW Biologics (HCWB) United States $0.055B 0.00
Enzo Biochem (ENZ) United States $0.055B 0.00
Intensity Therapeutics (INTS) United States $0.054B 0.00
AVROBIO (AVRO) United States $0.053B 0.00
Genenta Science S.p.A (GNTA) Italy $0.053B 0.00
Checkpoint Therapeutics (CKPT) United States $0.051B 0.00
ARCA Biopharma (ABIO) United States $0.050B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.050B 0.00
Prenetics Global (PRE) Cayman Islands $0.045B 0.00
NKGen Biotech (NKGN) United States $0.045B 0.00
Quince Therapeutics (QNCX) United States $0.045B 0.00
Clene (CLNN) United States $0.045B 0.00
Bolt Biotherapeutics (BOLT) United States $0.044B 0.00
Dyadic (DYAI) United States $0.044B 0.00
Ocean Biomedical (OCEA) United States $0.043B 0.00
Immuneering (IMRX) United States $0.042B 0.00
Beyond Air (XAIR) United States $0.042B 0.00
Apollomics (APLM) United States $0.042B 0.00
OKYO Pharma (OKYO) $0.042B 0.00
Bionano Genomics (BNGO) United States $0.042B 0.00
Aadi Bioscience (AADI) United States $0.041B 0.00
Carmell (CTCX) United States $0.040B 0.00
Cara Therapeutics (CARA) United States $0.038B 0.00
Ocuphire Pharma (OCUP) United States $0.038B 0.00
Estrella Immunopharma (ESLA) United States $0.038B 0.00
Cyclo Therapeutics (CYTH) United States $0.037B 0.00
SAB Biotherapeutics (SABS) United States $0.037B 0.00
Promis Neurosciences (PMN) Canada $0.037B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.036B 0.00
NextCure (NXTC) United States $0.036B 0.00
BRIACELL THERAP (BCTX) Canada $0.036B 0.00
Xilio Therapeutics (XLO) United States $0.035B 0.00
Eyenovia (EYEN) United States $0.034B 0.00
IN8bio (INAB) United States $0.033B 0.00
Fortress Biotech (FBIO) United States $0.033B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.032B 0.00
Theratechnologies (THTX) Canada $0.031B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.031B 0.00
MiNK Therapeutics (INKT) United States $0.030B 0.00
Femasys (FEMY) United States $0.029B 0.00
Dare Bioscience (DARE) United States $0.029B 0.00
Aprea Therapeutics (APRE) United States $0.029B 0.00
Spruce Biosciences (SPRB) United States $0.029B 0.00
Lexaria Bioscience (LEXX) Canada $0.028B 0.00
BioAffinity Technologies (BIAF) United States $0.028B 0.00
Evogene (EVGN) Israel $0.027B 0.00
Forte Biosciences (FBRX) United States $0.027B 0.00
Pluri (PLUR) Israel $0.025B 0.00
Sensei Biotherapeutics (SNSE) United States $0.025B 0.00
UNITY Biotechnology (UBX) United States $0.025B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.024B 0.00
Lumos Pharma (LUMO) United States $0.022B 0.00
Lisata Therapeutics (LSTA) United States $0.022B 0.00
Biora Therapeutics (BIOR) United States $0.022B 0.00
Synlogic (SYBX) United States $0.022B 0.00
Evaxion Biotech (EVAX) Denmark $0.021B 0.00
RenovoRx (RNXT) United States $0.020B 0.00
Vincerx Pharma (VINC) United States $0.019B 0.00
Aptose Biosciences (APTO) Canada $0.018B 0.00
Galecto (GLTO) Denmark $0.018B 0.00
Benitec Biopharma (BNTC) United States $0.018B 0.00
KALA BIO (KALA) United States $0.017B 0.00
Orgenesis (ORGS) United States $0.017B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.017B 0.00
VBI Vaccines (VBIV) United States $0.017B 0.00
ABVC BioPharma (ABVC) United States $0.017B 0.00
Talis Biomedical (TLIS) United States $0.016B 0.00
Aytu BioPharma (AYTU) United States $0.016B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.016B 0.00
Vaxxinity (VAXX) United States $0.015B 0.00
Cocrystal Pharma (COCP) United States $0.015B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.015B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.014B 0.00
IMMURON (IMRN) Australia $0.014B 0.00
Imunon (IMNN) United States $0.014B 0.00
Semper Paratus Acquisition (TVGN) United States $0.013B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.013B 0.00
Purple Biotech (PPBT) Israel $0.013B 0.00
Senti Biosciences (SNTI) United States $0.013B 0.00
Elevai Labs (ELAB) United States $0.012B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.012B 0.00
Galera Therapeutics (GRTX) United States $0.011B 0.00
Monopar Therapeutics (MNPR) United States $0.011B 0.00
Prana Biotechnology (ATHE) Australia $0.011B 0.00
Organovo Holdings (ONVO) United States $0.010B 0.00
BioCardia (BCDA) United States $0.010B 0.00
Telesis Bio (TBIO) United States $0.010B 0.00
Moleculin Biotech (MBRX) United States $0.010B 0.00
AEterna Zentaris (AEZS) Canada $0.010B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.009B 0.00
Eterna Therapeutics (ERNA) United States $0.009B 0.00
Virios Therapeutics (VIRI) United States $0.009B 0.00
Biofrontera (BFRI) United States $0.009B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
Biorestorative Therapies (BRTX) United States $0.008B 0.00
Cyclerion Therapeutics (CYCN) United States $0.008B 0.00
NuCana (NCNA) United Kingdom $0.008B 0.00
Bionomics (BNOX) Australia $0.008B 0.00
TFF Pharmaceuticals (TFFP) United States $0.008B 0.00
Pulmatrix (PULM) United States $0.008B 0.00
Pasithea Therapeutics (KTTA) United States $0.008B 0.00
Trevena (TRVN) United States $0.007B 0.00
Psyence Biomedical (PBM) United States $0.007B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.007B 0.00
Vaccinex (VCNX) United States $0.007B 0.00
Chemomab Therapeutics (CMMB) Israel $0.007B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.007B 0.00
AquaBounty Technologies (AQB) United States $0.007B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.007B 0.00
Tenax Therapeutics (TENX) United States $0.007B 0.00
Kineta (KA) United States $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.007B 0.00
Atrinsic (PTIX) United States $0.007B 0.00
Cadrenal Therapeutics (CVKD) United States $0.007B 0.00
EFFECTOR Therapeutics (EFTR) United States $0.007B 0.00
Enveric Biosciences (ENVB) United States $0.007B 0.00
Titan Pharmaceuticals (TTNP) United States $0.006B 0.00
Kintara Therapeutics (KTRA) United States $0.006B 0.00
Novogen (KZIA) Australia $0.006B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
First Wave BioPharma (FWBI) United States $0.006B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.005B 0.00
Silo Pharma (SILO) United States $0.005B 0.00
Palisade Bio (PALI) United States $0.005B 0.00
PaxMedica (PXMD) United States $0.005B 0.00
GT Biopharma (GTBP) United States $0.005B 0.00
Bright Minds Biosciences (DRUG) United States $0.005B 0.00
Alzamend Neuro (ALZN) United States $0.005B 0.00
Synaptogenix (SNPX) United States $0.005B 0.00
NexImmune (NEXI) United States $0.005B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.005B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.004B 0.00
Soligenix (SNGX) United States $0.004B 0.00
Exicure (XCUR) United States $0.004B 0.30
Artelo Biosciences (ARTL) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Portage Biotech (PRTG) $0.004B 0.00
Cingulate (CING) United States $0.004B 0.00
Longeveron (LGVN) United States $0.004B 0.00
TRACON Pharmaceuticals (TCON) United States $0.004B 0.00
GENPREX (GNPX) United States $0.004B 0.00
Ensysce Biosciences (ENSC) United States $0.004B 0.00
Seelos Therapeutics (SEEL) United States $0.004B 0.00
Mustang Bio (MBIO) United States $0.004B 0.00
Revelation Biosciences (REVB) United States $0.003B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.003B 0.00
GeoVax Labs (GOVX) United States $0.003B 0.00
Avalon GloboCare (ALBT) United States $0.003B 0.00
ARAVIVE, INC (ARAV) United States $0.003B 0.00
Biophytis SA (BPTS) France $0.003B 0.00
Allarity Therapeutics (ALLR) United States $0.003B 0.00
Invo BioScience (INVO) United States $0.003B 0.00
Onconetix (ONCO) United States $0.003B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
CNS Pharmaceuticals (CNSP) United States $0.002B 0.00
Notable Labs (NTBL) United States $0.002B 0.00
ThermoGenesis Holdings (THMO) United States $0.002B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
NeuBase Therapeutics (NBSE) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.001B 0.00
GRI Bio (GRI) United States $0.001B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.001B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.001B 0.00
Bone Biologics (BBLG) United States $0.001B 0.00
Sunshine Biopharma (SBFM) United States $0.001B 0.00
Aptevo Therapeutics (APVO) United States $0.000B 0.00
Sinovac Biotech (SVA) China $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00